Search Results - Wanming Hu

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Enhancer of zeste homolog 2 is a negative prognostic biomarker and correlated with immune infiltrates in meningioma by Jing Zeng, Jing Zeng, Lu Sun, Lu Sun, Jiaming Huang, Jiaming Huang, Xia Yang, Xia Yang, Wanming Hu, Wanming Hu

    Published in Frontiers in Neuroscience (2022-11-01)
    Get full text
    Article


  2. 2

    m6A regulator-based molecular classification and hub genes associated with immune infiltration characteristics and clinical outcomes in diffuse gliomas by Jie Lu, Siyu Chen, Wanming Hu, Ke Sai, Depei Li, Pingping Jiang

    Published in BMC Medical Genomics (2025-02-01)
    Get full text
    Article


  3. 3

    Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up by Hao Duan, Zhenqiang He, Zhenghe Chen, Yukun Chen, Wanming Hu, Ke Sai, Xiangheng Zhang, Jianchuan Xia, Yongqiang Li, Ranyi Liu, Chaowei Zou, Zhongping Chen, Yonggao Mou

    Published in BMC Immunology (2024-12-01)
    Get full text
    Article


  4. 4

    CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas by Depei Li, Depei Li, Wanming Hu, Wanming Hu, Xiaoping Lin, Xiaoping Lin, Ji Zhang, Ji Zhang, Zhenqiang He, Zhenqiang He, Sheng Zhong, Sheng Zhong, Xia Wen, Xia Wen, Peiyu Zhang, Peiyu Zhang, Xiaobing Jiang, Xiaobing Jiang, Hao Duan, Hao Duan, Chengcheng Guo, Chengcheng Guo, Jian Wang, Jian Wang, Jing Zeng, Jing Zeng, Zhongping Chen, Zhongping Chen, Yonggao Mou, Yonggao Mou, Ke Sai, Ke Sai

    Get full text
    Article


  5. 5

    Whole‐exome sequencing in clear cell sarcoma of soft tissue uncovers novel prognostic categorization and drug targets by Jingjing Li, Chao Chen, Wei Liu, Songming Liu, Wanming Hu, Xiaoyan Gao, Geng Liu, Dandan Li, Ya Ding, Xizhi Wen, Xiuqing Zhang, Yong Hou, Xing Zhang, Bo Li, Xiaoshi Zhang, Xi Zhang

    Published in Clinical and Translational Medicine (2021-12-01)
    Get full text
    Article


  6. 6

    Screening and verification of antiviral compounds against HSV-1 using a method based on a plaque inhibition assay by Yingxian Yin, Jiahui Li, Ling Su, Zhiying Ou, Qingqun Lv, Misi Xiao, Changbing Wang, Dan Zeng, Yiling Gu, Fengxia Yang, Minxia Chen, Shaojuan Feng, Wanming Hu, Fengling Bu, Bing Zhu, Yi Xu

    Published in BMC Infectious Diseases (2023-12-01)
    Get full text
    Article


  7. 7

    A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma by Xinke Zhang, Zihan Zhao, Ruixuan Wang, Haohua Chen, Xueyi Zheng, Lili Liu, Lilong Lan, Peng Li, Shuyang Wu, Qinghua Cao, Rongzhen Luo, Wanming Hu, Shanshan lyu, Zhengyu Zhang, Dan Xie, Yaping Ye, Yu Wang, Muyan Cai

    Published in Nature Communications (2024-05-01)
    Get full text
    Article


  8. 8

    Lorlatinib for ALK‐fused, infant‐type hemispheric glioma with lung metastasis: a case report by Mingyao Lai, Shaoqun Li, Hainan Li, Qingjun Hu, Juan Li, Jiangfen Zhou, Ruyu Ai, Junjie Zhen, Zhaoming Zhou, Lichao Wang, Yangqiong Zhang, Wanming Hu, Li Yuan, Xuejiao Ma, Xing Zhang, Chao Song, Zhi Li, Linbo Cai

    Get full text
    Article


  9. 9

    Effect of the mRNA decapping enzyme scavenger (DCPS) inhibitor RG3039 on glioblastoma by Hao Duan, Yuan Xie, Suwen Wu, Guangyin Zhao, Zhen Zeng, Hongrong Hu, Yanjiao Yu, Wanming Hu, Yuanzhong Yang, Yukun Chen, Haoqun Xie, Zexin Chen, Gao Zhang, Keith T. Flaherty, Shanshan Hu, Haineng Xu, Wenjuan Ma, Yonggao Mou

    Published in Journal of Translational Medicine (2024-09-01)
    Get full text
    Article


  10. 10

    Pediatric central nervous system tumor with CIC::LEUTX fusion: a diagnostic challenge by Yanghao Hou, Yanru Du, Juan Wang, Xinke Zhang, Xueyan Zhao, Xinyi Xian, Li Yuan, Haigang Li, Yu Wang, Shaoyan Xi, Guan Huang, Wenbiao Zhu, Juan Wang, Jin Zhu, Qiubo Yu, Youde Cao, JingXian Wu, Jing Zeng, Gehong Dong, Wanming Hu

    Published in Acta Neuropathologica Communications (2024-06-01)
    Get full text
    Article


  11. 11

    Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in <i>EGFR</i>-Mutant Stage III-pN2 Lung Adenocarcinoma by Qiwen Li, Li Ma, Bo Qiu, Yuzhi Wen, Wenhua Liang, Wanming Hu, Naibin Chen, Tian Zhang, Shuangbing Xu, Lingjuan Chen, Minzhang Guo, Yi Zhao, Songran Liu, Jinyu Guo, Junye Wang, Siyu Wang, Xin Wang, Qingsong Pang, Hao Long, Hui Liu

    Published in Current Oncology (2021-04-01)
    Get full text
    Article


  12. 12

    Neoadjuvant sintilimab and chemotherapy followed by transoral surgery for HPV-positive resectable oropharyngeal cancer: a single-arm, two-centre, phase 2 trialResearch in context by Shida Yan, Xing Zhang, Fengjiao Li, Ankui Yang, Hui Li, Wanming Hu, Qiaohong Lin, Xiyuan Li, Mingyuan Du, Jingtao Chen, Guodong Man, Jianwei Zhang, Xuemei Fang, Li Ning, Shiting Zhang, Lili Han, Yanmei Ma, Jun Wang, Shuwei Chen, Ming Song

    Published in EClinicalMedicine (2025-08-01)
    Get full text
    Article


  13. 13

    Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabine/Nab-Paclitaxel by Qiuxia Yang, Yize Mao, Yulong Han, Kailai Li, Wanming Hu, Jianyao Zhou, Xuejun Gong, Shuxiang Huang, Rong Zhang, Lizhi Liu, Ningning Niu, Yixiong Li, Liandong Ji, Xiaoping Yi, Wufeng Xue, Dong Ni, Wenjun Mao, Peng Luo, Dong Luo, Jun Cheng

    Published in Research (2025-01-01)
    Get full text
    Article


  14. 14

    Pathological regression patterns following neoadjuvant chemo-immunotherapy in head and neck squamous cell carcinoma: a pilot study by Dikan Wang, Dikan Wang, Fanning Zeng, Fanning Zeng, Sien Zhang, Sien Zhang, Wanming Hu, Yahui Wang, Yahui Wang, Daiqiao Ouyang, Daiqiao Ouyang, Bin Zeng, Bin Zeng, Guozhong Zeng, Guozhong Zeng, Jingyuan Li, Jingyuan Li, Guiqing Liao, Guiqing Liao, Yujie Liang, Yujie Liang

    Published in Frontiers in Immunology (2025-08-01)
    Get full text
    Article


  15. 15

    FTO-mediated DSP m6A demethylation promotes an aggressive subtype of growth hormone-secreting pituitary neuroendocrine tumors by Yunzhi Zou, Xiaoqiong Bao, Depei Li, Zhen Ye, Rong Xiang, Yuanzhong Yang, Zhe Zhu, Ziming Chen, Lingxing Zeng, Chunling Xue, Hongzhe Zhao, Boyuan Yao, Qilin Zhang, Zeming Yan, Zekun Deng, Jintong Cheng, Guanghao Yue, Wanming Hu, Jixiang Zhao, Ruihong Bai, Zhenhua Zhang, Aiqun Liu, Jialiang Zhang, Zhixiang Zuo, Xiaobing Jiang

    Published in Molecular Cancer (2024-09-01)
    Get full text
    Article


  16. 16

    Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target by Hao Duan, Jianlan Ren, Shiyou Wei, Zhenyu Yang, Chuan Li, Zhenning Wang, Meichen Li, Zhi Wei, Yu Liu, Xiuqi Wang, Hongbin Lan, Zhen Zeng, Maodi Xie, Yuan Xie, Suwen Wu, Wanming Hu, Chengcheng Guo, Xiangheng Zhang, Lun Liang, Chengwei Yu, Yanhao Mou, Yu Jiang, Houde Li, Eric Sugarman, Rebecca A. Deek, Zexin Chen, Tao Li, Yaohui Chen, Maojin Yao, Likun Chen, Lunxu Liu, Gao Zhang, Yonggao Mou

    Published in Genome Medicine (2024-11-01)
    Get full text
    Article


Search Tools: